2024 Agenda

6:00a - 7:00a - Breakfast/Registration- Exhibit Hall

7:00a - 9:30a - VASCULAR MEDICINE

  • Welcome - Glenn LaMuraglia
  • New approaches to cholesterol management, are statins still the gold standard? - Janet Lo
  • Cardiac risk stratification for vascular disease: who should get it and is it useful? - Eric Isselbacher
  • The combustion vs nicotine effects on the vascular patients: issues and strategies to make them stop - Nancy Rigotti
  • Intraoperative monitoring of ACT/TEG and other clotting parameters: are they worth it? - Jerome Crowley
  • Vascular disease and antiplatelet agents: who should get them and which one - Robert Schainfeld
  • In atherosclerotic obstructive disease, who should get which anticoagulants for their PAD and who should avoid them - Ido Weinberg
  • Aortic focal dissection/hematomas and aortic ulcers: How often to follow and when should they be treated - Eric Isselbacher
  • Incidental findings: webs, local dissections and fibromuscular dysplasia, do they need to be followed or treated? - Gauray Parmar
  • Panel Discussion

9:30a - 10:00a - Coffee/Snack Break - Exhibit Hall

10:00a - 12:00p - OCCLUSIVE DISEASE I

  • What is the optimal approach for the evaluation and treatment of the patient with acute limb ischemia - David Stone
  • With the great results of exercise therapy for claudication, should any claudicants be treated and which ones? - Dejah Judelson
  • Limb staging in CLTI - WIFI, GLASS, and why it matters - Michael Conte
  • What are the results of lower extremity prosthetic bypass, do adjuncts improve patency? - Alan Hamdan
  • Does a failed PTA limit open surgical options for lower extremity revascularization? - Jocelyn Beach
  • Common femoral artery occlusive disease, who should get PTA, endarterectomy, or bypass - Jeffery Syracuse
  • Pedal artery calcification and its impact on CLTI treatment outcomes - Michael Conte
  • Panel Discussion

12:00p - 1:00p - Lunch

1:00p - 2:45p - ANEURYSM I

  • The patient with type B dissection: How to approach and manage them - Jahan Mohebali
  • The consultation of the patient with the small AAA, how to optimally manage them and slow their growth rate? - Patric Liang
  • Contemporary SVS guidelines for AAA, should there be a gender, growth rate and age consideration? - Lars Stangenberg
  • The predictive models of AAA outcomes, how well do they help you treat AAA patients - David Stone
  • IFU criteria for EVAR grafts, how do they impact long term outcomes? - Laura Boitano
  • In urgent cases should chimney/snorkels be used or simple PMEGs: what are the outcomes? - Jessica Simons
  • Panel Discussion

2:45p - 3:15p - Break - Visit the Exhibitors

3:15p - 5:45p - VENOUS DISEASE

  • Recanalization of acute and chronic deep venous obstruction, are they different? - Dania Daye
  • Pelvic Venous Disorders including the SVP classification: How to approach them - Cheih-Min Fan
  • Phlebolymphedema: What is it and how does it impact the treatment of venous disease - Thomas O'Donnell
  • Updates in the management of superficial and deep acute venous thrombosis - Luis Suarez
  • Preservation of the saphenous vein during management of symptomatic tributaries - Julianne Stoughton
  • Trunkal vein ablation: What are the advantages of thermal vs nonthermal methods - Sherry Scovell
  • Problem Case Presentation

5:45p - 6:45p - Problem Case Presentation - TBD

6:45p - Cocktails & hors d'oeuvres

6:15a - 7:15a - Breakfast/Registration- Exhibit Hall

7:15a - 9:30a - CAROTID

  • Effect of Optimal Medical Therapy on the Natural history of carotid stenosis, should the asymptomatic patient be treated? - Scott Silverman
  • Asymptomatic carotid disease is not a medical illness like DM, many are best served by intervention, which ones? - Bruce Perler
  • When is standard duplex evaluation insufficient for evaluating patients with extracranial cerebrovascular disease? - Javier Romero
  • Shaking limb syndrome, carotid webs: unusual indications for carotid interventions to prevent strokes - Bruce Perler
  • How to optimally monitor cerebral perfusion in patients during carotid procedures? - Chris Stapleton
  • The patient with the acute stroke from the carotid: when to intervene early and when to delay revascularization - Natalia Rost
  • TCAR and transfemoral carotid stenting approval by CMS, is it justified? - Nikolas Zacharias
  • Non-atherosclerotic carotid disease: fibromuscular dysplasia, dissection, aneurysms, vasculitis, how should they be treated? - Aneesh Singhal
  • Panel

9:30a - 10:00a - Coffee Break - Exhibit Hall

10:00a - 12:00p - MISCELLANEOUS I

  • Acute Kidney injury in the vascular patient, what is the best way to avoid it? - David Steele
  • The patient with severe renal artery stenosis, should any be treated? - Douglas Drachman
  • How to evaluate and salvage the non-maturing/failing AVF - Louis Nguyen
  • Despite NY Times, etc, Industry-Physician Partnerships are justified and beneficial to patients: How to do it - Bruce Perler
  • Introduction to Linton Lecture - Glenn LaMuraglia
  • Linton Lecture: Evidence-based treatment of advanced Limb ischemia: a journey for our specialty - Michael Conte

12:00p - 1:00p - Lunch

1:00p - 2:45p - ANEURYSM II

  • What are some radiology tips on how to identify the type of endoleak present after EVAR - Brian Ghoshhajra
  • Branched endovascular devices when are they useful and when to avoid them? - Marc Schermerhorn
  • Contemporary controversies of Rx ruptured AAA with open surgery or EVAR - Jahan Mohebali
  • Fenestrated versus open surgery for para/juxtarenal aneurysm: what parameters determine the correct choice? - Matthew Eagleton
  • The type II endoleak problem after EVAR: can they be avoided and when to treat them - Nicholas Swerlow
  • Visceral and renal artery aneurysms, which ones require treatment? - Abhisekh Mohapatra
  • Panel

2:45p - 3:15p - Coffee Break - Exhibit Hall

3:10p - 5:30p - OCCLUSIVE DISEASE II

  • The TASC C/D aortoiliac disease patient, which patients benefit from open vs endovascular surgery? - Mark Wyers
  • DCB, Atherectomy and Shockwave balloons, when are they cost-effective for treating PAD - Mohamad Hussain
  • Acute and chronic mesenteric ischemia, which ones are best treated by open surgery - Nikolas Zacharias
  • What has the BEST-CLI taught us for patients with CLTI? - Matthew Menard
  • With the results of the BASIL trial, in CLTI are patients with SFA/popliteal disease or tibial disease different entities? - Alik Farber
  • Problem Case Presentation

5:30p - Adjourn

6:00a - 7:00a - Breakfast/Registration- Exhibit Hall

7:30a - 930a - TECHNIQUE I - HOW I DO IT

  • Foam sclerotherapy(Air, Co2,Varithena): How I do it and tricks to avoid DVT and other complications - Sherry Scovell
  • Exposure of the proximal R and L subclavian arteries in trauma or a TOS gone bad - Peter Fagenholz
  • Exposure for the Spine surgeon: how to best expose lumbar and thoracic levels - Marcus Semel
  • Challenging exposure of the proximal abdominal aorta and its branches, which incision/technique to use - Jahan Mohebali
  • Popliteal aneurysm repair, how I choose the different approaches - Nikolas Zacharias
  • How to do osseointegration and target muscle innervation - Jeffery Kalish
  • Deep venous arterialization for the profoundly ischemic foot - Anahita Dua
  • Panel

9:30a - 9:45a - Break - Exhibit Hall

9:45a - 11:45a - TECHNIQUE II - HOW I DO IT

  • How to effectively use percutaneous suction and mechanical thrombectomy - Luis Suarez
  • How to achieve antegrade/retrograde endovascular mesenteric revascularization - Payam Salehi
  • Identifying the right patient and undertaking successful percutaneous EVAR/TEVAR - Abhisekh Mohapatra
  • Percutaneous approaches to the problematic dialysis AV fistula - Zubin Irani
  • The tortuous and difficult anatomy for renal/visceral vessel percutaneous access, which types of wires and catheters provide best success - Jahan Mohebali
  • The use of IVUS for placement and techniques for the challenging retrieval of IVC filters - Junaid Malek
  • Non-femoral Artery Access Options for treating occlusive vascular disease - Rahul Sakhuja
  • Panel

12:00p - Adjourn